Skip to content

Discovery and mechanism of pathogenic gene mutations in hypotension families

Discovery and mechanism of pathogenic gene mutations in hypotension families

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033077
Enrollment
Unknown
Registered
2020-05-19
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypotension

Interventions

primary hypotension group vs. healthy control group:N/A

Sponsors

Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as primary hypotension; 2. Aged >18 years; 3. Patients of low blood pressure volunteers and healthy blood pressure volunteers (people aged 18-30).

Exclusion criteria

Exclusion criteria: 1. Women in pregnancy or lactation; 2. Patients with malignant tumor and other serious diseases; 3. The patients who have been combined with the drugs that clearly cause the related adverse reactions; 4. Patients with liver and kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
BP;genetype;

Countries

China

Contacts

Public ContactLong Mo

Xiangya Hospital of Central South University

diagnostics@126.com+86 17708473296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026